GALIXIMAB
UNII S9OX9692ZB

Substance Identification & Data

This profile provides standardized clinical and technical data for Galiximab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) S9OX9692ZB.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 357613-77-5 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

S9OX9692ZB

CAS Registry Number

357613-77-5

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

GALIXIMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C26447

National Cancer Institute reference terminology for clinical and research data.

INN ID

8339

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

OO-29

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Galiximab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

GALIXIMAB

Common Names & Synonyms

GALIXIMAB [INN]

GALIXIMAB [USAN]

GALIXIMAB [WHO-DD]

IMMUNOGLOBULIN G1, ANTI-(HUMAN CD80 (ANTIGEN)) (HUMAN-MACACA IRUS MONOCLONAL IDEC-114 HEAVY CHAIN), DISULFIDE WITH HUMAN-MACACA IRUS MONOCLONAL IDEC-114 .LAMBDA.-CHAIN, DIMER

IMMUNOGLOBULIN G1, ANTI-(HUMAN CD80 (ANTIGEN)) (HUMAN-MACACA IRUS MONOCLONAL IDEC-114 HEAVY CHAIN), DISULPHIDE WITH HUMAN-MACACA IRUS MONOCLONAL IDEC-114 .LAMBDA.-CHAIN, DIMER

Technical Codes

IDEC-114

External Clinical & Regulatory Resources

Previous UNIIS9OPP6JJQ1

Next UNIIS9P1NV44R8